1. Home
  2. BZH vs CDNA Comparison

BZH vs CDNA Comparison

Compare BZH & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beazer Homes USA Inc.

BZH

Beazer Homes USA Inc.

HOLD

Current Price

$20.28

Market Cap

672.0M

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$19.48

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZH
CDNA
Founded
1985
1998
Country
United States
United States
Employees
N/A
650
Industry
Homebuilding
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
672.0M
1.0B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
BZH
CDNA
Price
$20.28
$19.48
Analyst Decision
Strong Buy
Buy
Analyst Count
3
7
Target Price
$32.00
$26.67
AVG Volume (30 Days)
403.3K
768.6K
Earning Date
01-29-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.52
1.22
Revenue
$2,371,555,000.00
$357,998,000.00
Revenue This Year
$7.40
$14.11
Revenue Next Year
$12.09
$11.75
P/E Ratio
$13.34
$16.03
Revenue Growth
1.77
14.46
52 Week Low
$17.37
$10.96
52 Week High
$29.30
$25.95

Technical Indicators

Market Signals
Indicator
BZH
CDNA
Relative Strength Index (RSI) 34.71 58.23
Support Level $20.00 $19.01
Resistance Level $22.04 $20.61
Average True Range (ATR) 0.61 0.80
MACD -0.24 -0.11
Stochastic Oscillator 6.07 45.12

Price Performance

Historical Comparison
BZH
CDNA

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: